New insights into the mechanisms of the vasorelaxant effects of apocynin in rat thoracic aorta

Fundamental and Clinical Pharmacology

Volumn 27, Issue 3, 2013, Pages 262-270

  Senejoux, François ^a   Girard Thernier, Corine ^a   Berthelot, Alain ^a   Bévalot, Françoise ^a   Demougeot, Céline ^a  

^a UNIVERSITÉ DE FRANCHE COMTÉ   (France)

Author keywords

Apocynin; Mechanisms; NADPH oxidase; Rat aorta; Vasodilation

Indexed keywords

4 AMINOPYRIDINE; ADENOSINE TRIPHOSPHATE SENSITIVE POTASSIUM CHANNEL; APAMIN; APOCYNIN; CALCIUM ION; CHARYBDOTOXIN; GLIBENCLAMIDE; IBERIOTOXIN; INDOMETACIN; NITRIC OXIDE SYNTHASE; PHENYLEPHRINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA CONSTRICTION; ARTERIAL PRESSURE; ARTICLE; BLOOD VESSEL REACTIVITY; CALCIUM CELL LEVEL; CALCIUM MOBILIZATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; HEART RATE; HYPERTENSION; IN VITRO STUDY; IN VIVO STUDY; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SARCOPLASMIC RETICULUM; SPONTANEOUSLY HYPERTENSIVE RAT; THORACIC AORTA; VASCULAR RING; VASCULAR SMOOTH MUSCLE; VASODILATATION;

ACETOPHENONES; ANIMALS; ANTIHYPERTENSIVE AGENTS; AORTA, THORACIC; CALCIUM; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOTHELIUM, VASCULAR; HYPERTENSION; INJECTIONS, INTRAVENOUS; KATP CHANNELS; MALE; MUSCLE, SMOOTH, VASCULAR; NITRIC OXIDE; RATS; RATS, INBRED SHR; RATS, WISTAR; VASOCONSTRICTION; VASODILATION; VASODILATOR AGENTS;

EID: 84877810330     PISSN: 07673981     EISSN: 14728206     Source Type: Journal    
DOI: 10.1111/j.1472-8206.2011.01025.x     Document Type: Article

References (35)

1. Basu K., Dasgupta B., Bhattacharya S.K., Debnath P.K.Chemistry and pharmacology of apocynin, isolated from Picrorhiza kurroa Royle ex Benth. Curr. Sci. (1971) 40 603-604.
2. Kobayashi S.D., Voyich J.M., Burlak C., DeLeo F.R.Neutrophils in the innate immune response. Arch. Immunol. Ther. Exp. (Warsz) (2005) 53 505-517.
3. Ximenes V.F., Kanegae M.P., Rissato S.R., Galhiane M.S.The oxidation of apocynin catalyzed by myeloperoxidase: proposal for NADPH oxidase inhibition. Arch. Biochem. Biophys. (2007) 457 134-141.
4. Paravicini T.M., Touyz R.M.NADPH oxidases, reactive oxygen species, and hypertension: clinical implications and therapeutic possibilities. Diabetics Care (2008) 2 S170-S180.
5. Riganti C., Gazzano E., Polimeni M., Costamagna C., Bosia A., Ghigo D.Diphenyleneiodonium inhibits the cell redox metabolism and induces oxidative stress. J. Biol. Chem. (2004) 279 47726-47731.
6. Muijsers R.B.R., Van den Worm E., Folkerts G. et al.Apocynin inhibits peroxynitrite formation by murine macrophages. Br. J. Pharmacol. (2000) 130 932-936.
7. Unger B.S., Patil B.M.Apocynin improves endothelial function and prevents the development of hypertension in fructose fed rat. Indian J. Pharmacol. (2009) 41 208-212.
8. Costa C.A., Amaral T.A., Carvalho L.C. et al.Antioxidant treatment with tempol and apocynin prevents endothelial dysfunction and development of renovascular hypertension. Am. J. Hypertens. (2009) 22 1242-1249.
9. Lambeth J.D.NOX enzymes and the biology of reactive oxygen. Nat. Rev. Immunol. (2004) 4 181-189.
10. Heumüller S., Wind S., Barbosa-Sicard E. et al.Apocynin is not an inhibitor of vascular NADPH oxidases but an antioxidant. Hypertens. (2008) 51 211-217.
11. Riganti C., Costamagna C., Bosia A., Ghigo D.The NADPH oxidase inhibitor apocynin (acetovanillone) induces oxidative stress. Toxicol. Appl. Pharmacol. (2006) 212 179-187.
12. Wind S., Beuerlein K., Eucker T. et al.Comparative pharmacology of chemically distinct NADPH oxidase inhibitors. Br. J. Pharmacol. (2010) 161 885-898.
13. Han W.Q., Wong W.T., Tian X.Y. et al.Contributory role of endothelium and voltage-gated potassium channels in apocynin-induced vasorelaxations. J. Hypertens. (2010) 28 2102-2110.
14. Schlüter T., Steinbach A.C., Steffen A., Rettig R., Grisk O.Apocynin-induced vasodilation involves Rho kinase inhibition but not NADPH oxidase inhibition. Cardiovasc. Res. (2008) 80 271-279.
15. + channel activation to acetophenone analogues-mediated in vitro pulmonary artery relaxation of rat. Life Sci. (2006) 78 631-639.
16. Demougeot C., Prigent-Tessier A., Marie C., Berthelot A.Arginase inhibition reduces endothelial dysfunction and blood pressure rising in spontaneously hypertensive rats. J. Hypertens. (2005) 23 971-978.
17. Busse R., Edwards G., Félétou M., Fleming I., Vanhoutte P.M., Weston A.H.EDHF: bringing the concepts together. Trends Pharmacol. Sci. (2002) 23 74-80.
18. Mishra S.K., Abbot S.E., Choudhury Z. et al.Endothelium-dependent relaxation of rat aorta and main pulmonary artery by the phytoestrogens genistein and daidzein. Cardiovasc. Res. (2000) 46 539-546.
19. Nelson M.T., Quayle J.M.Physiological roles and properties of potassium channels in arterial smooth muscle. Am. J. Physiol. (1995) 268 799-822.
20. Cadorette C., Sicotte B., Brochu M., St-Louis J.Effects of potassium channel modulators on myotropic responses of aortic rings of pregnant rats. Am. J. Physiol. Heart Circ. Physiol. (2000) 278 567-576.
21. Diebolt M., Andriantsitohaina R.Wine polyphenols modulate calcium handling in rat aorta: involvement of nitric oxide pathway. Fundam. Clin. Pharmacol. (2002) 16 289-296.
22. Luksha L., Agewall S., Kublickiene K.Endothelium-derived hyperpolarizing factor in vascular physiology and cardiovascular disease. Atherosclerosis (2009) 202 330-344.
23. Török J.Histamine-induced relaxation in pulmonary artery of normotensive and hypertensive rats: relative contribution of prostanoids, nitric oxide and hyperpolarization. Physiol. Res. (2000) 49 107-114.
24. Hamilton C.A., Brosnan M.J., Al-Benna S., Berg G., Dominiczak A.F.NAD(P)H oxidase inhibition improves endothelial function in rat and human blood vessels. Hypertens. (2002) 40 755-762.
25. Pohl U., De Wit C., Gloe T.Large arterioles in the control of blood flow: role of endothelium dependent dilation. Acta Physiol. Scand. (2000) 168 505-510.
26. 2+-sensitive ion channels. Cell Calcium (2003) 34 211-229.
27. Lohn M., Furstenau M., Sagach V. et al.Ignition of calcium sparks in arterial and cardiac muscle through caveolae. Circ. Res. (2000) 87 1034-1039.
28. Marín J., Encabo A., Briones A., García-Cohen E.C., Alonso M.J.Mechanisms involved in the cellular calcium homeostasis in vascular smooth muscle: calcium pumps. Life Sci. (1999) 64 279-303.
29. 2+stores by specific inhibition of the endoplasmic reticulum Ca2(+)-ATPase. Proc. Natl Acad. Sci. USA. (1990) 87 2466-2470.
30. + channels in vascular smooth muscle cells. J. Smooth Muscle Res. (2008) 44 65-81.
31. + channels in the function of rat aortic smooth muscle cells. Br. J. Pharmacol. (2004) 143 303-317.
32. Holland J.A., Johnson D.K.Prevention of atherosclerosis using NADPH oxidase inhibitors. US Patent 5, 902, 831 (1999).
33. Yu J., Weïver M., Linhardt R.J., Dordick J.S.The role of the methoxyphenol apocynin, a vascular NADPH oxidase inhibitor, as a chemoprotective agent in the potential treatment of cardiovascular diseases. Curr. Vasc. Pharmacol. (2008) 6 204-217.
34. Just A., Olson A.J.M., Whitten C.L., Ahrendshorst W.J.Superoxide mediates acute renal vasoconstriction produced by angiotensin II and catecholamines by a mechanism independent of nitric oxide. Am. J. Physiol. Heart Circ. Physiol. (2007) 292 H83-H91.
35. Tang X.N., Cairns B., Cairns N., Yenari M.A.Apocynin improves outcome in experimental stroke with a narrow dose range. Neuroscience (2008) 154 556-562.